Acutaas Chemicals Q2 profit rises 71.4%, lifts FY27 outlook
NiveshIQ
NSE: ACUTAAS · Healthcare
Acutaas Chemicals Ltd.
₹3,892.60▼ ₹111.00 (-2.77%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on ACUTAAS. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Acutaas Chemicals Ltd.
Acutaas Chemicals Limited, headquartered in Surat, specializes in the research, development, manufacture, and sale of pharmaceutical intermediates for regulated and generic active pharmaceutical ingredients, as well as new chemical entities. The company also supplies specialty chemicals such as photoresist chemicals for semiconductor applications, electrolyte additives for lithium battery cells, and commodity chemicals for cosmetics, agrochemicals, and fine chemicals. In May 2025, Acutaas completed a 100% acquisition of Enchem Ami Organics, expanding its product portfolio and market reach. For FY2025, the company reported revenue of ₹1,462 crore and net income of ₹386 crore, reflecting a robust growth trajectory. Competitive positioning is strengthened by its diversified chemical offerings
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹717.47 Cr +16.33% | ₹1,007 Cr +40.34% | ₹1,339 Cr +33.02% |
| EBITDA Margin | 17.91% | 23.05% | 35.87% |
| Net Profit | ₹42.77 Cr -48.65% | ₹158.71 Cr +271.06% | ₹356.26 Cr +124.46% |
| EPS | ₹11.67 | ₹19.81 | ₹43.51 |
Annual figures in Indian Rupees (Crores). Source: company filings (NSE).
Recent News
Acutaas Chemicals Ltd (BOM:543349) (Q2 2027) Earnings Call Highl
Acutaas Chemicals Ltd (BOM:543349) (Q2 2027) Earnings Call Highlights: Revenue Surges 42. ...
🔒
+ 3 more stories about Acutaas Chemicals Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q2FY27 results: revenue ₹437 Cr, PAT ₹125 Cr, EPS ₹15.29, EBITDA margin 40.3%. Growth context: revenue YoY +42.7%, PAT YoY +73.3%, revenue QoQ +32.5%, PAT QoQ +68.6%.
Realisations, demand recovery, cost efficiency, capacity utilisation, and margin discipline are the primary drivers for ...
FY26 (last completed FY) delivered revenue ₹1, 339 Cr, PAT ₹356 Cr, EBITDA margin 35.9%, and EPS ₹43.51, with YoY revenu...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantMore Healthcare stocks
Wockhardt Ltd.Yatharth Hospital & Trauma Care Services Ltd.Zydus Lifesciences Ltd.Aarti Drugs Ltd.Aarti Pharmalabs Ltd.Abbott India Ltd.Advanced Enzyme Tech Ltd.Ajanta Pharmaceuticals Ltd.Akums Drugs and Pharmaceuticals Ltd.Alembic Pharmaceuticals Ltd.Alivus Life Sciences Ltd.Alkem Laboratories Ltd.
Everything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for ACUTAAS
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track ACUTAAS alongside your other holdings
Unlock full ACUTAAS research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Acutaas Chemicals Ltd.?
NiveshIQ detects active intelligence signals for Acutaas Chemicals Ltd. (ACUTAAS) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Acutaas Chemicals Ltd.?
Acutaas Chemicals Ltd. operates in the Healthcare sector with a market capitalisation of ₹2,706,822.9L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.